Ceribell, Inc., a US-based company that deals with AI-powered point-of-care neurodiagnostics, announced on Thursday that it has named Louisa Daniels as its new general counsel.

In the new role, Daniels is to head the firm's legal, governance, compliance, and ethics functions.

Daniels has more than 30 years of experience in the biopharma industry. She has earlier served as chief legal officer, general counsel and chief compliance officer for Recursion Pharmaceuticals, vice president and assistant general counsel at Pfizer, where she worked at various times as chief counsel for Global Product Development; Global Commercial Operations, Strategy & Portfolio Management; and Pharmatherapeutics R&D. She has also served as in-house counsel at Elan Pharmaceuticals and Tularik Inc.